AU3954799A - Acylated alkylated cyclodextrin derivatives and their use as carriers for medicaments - Google Patents
Acylated alkylated cyclodextrin derivatives and their use as carriers for medicamentsInfo
- Publication number
- AU3954799A AU3954799A AU39547/99A AU3954799A AU3954799A AU 3954799 A AU3954799 A AU 3954799A AU 39547/99 A AU39547/99 A AU 39547/99A AU 3954799 A AU3954799 A AU 3954799A AU 3954799 A AU3954799 A AU 3954799A
- Authority
- AU
- Australia
- Prior art keywords
- medicaments
- carriers
- cyclodextrin derivatives
- alkylated cyclodextrin
- acylated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medical Informatics (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP16446598 | 1998-05-29 | ||
JP10/164465 | 1998-05-29 | ||
PCT/JP1999/002806 WO1999062958A1 (fr) | 1998-05-29 | 1999-05-27 | Derives de cyclodextrine alkyle acyle et leur utilisation en tant qu'excipients pour medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3954799A true AU3954799A (en) | 1999-12-20 |
Family
ID=15793704
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU39547/99A Abandoned AU3954799A (en) | 1998-05-29 | 1999-05-27 | Acylated alkylated cyclodextrin derivatives and their use as carriers for medicaments |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1084149A1 (fr) |
JP (1) | JP2002517521A (fr) |
AU (1) | AU3954799A (fr) |
WO (1) | WO1999062958A1 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6835717B2 (en) | 2000-03-08 | 2004-12-28 | The Johns Hopkins University School Of Medicine | β-cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases |
JP2003063965A (ja) * | 2001-06-13 | 2003-03-05 | Otsuka Pharmaceut Factory Inc | 注射用シロスタゾール水性製剤 |
AU2003202557A1 (en) * | 2002-01-15 | 2003-07-30 | Nycomed Gmbh | Pantoprazole cyclodextrin inclusion complexes |
KR101129816B1 (ko) * | 2003-03-28 | 2012-03-26 | 아레스 트레이딩 에스.아. | 클라드리빈의 경구용 제형 |
FR2903987B1 (fr) * | 2006-07-21 | 2012-12-21 | Centre Nat Rech Scient | Nouveaux derives de cyclodextrines amphiphiles, leur utilisation dans les domaines pharmaceutiques,cosmetiques, alimentaires et leur application a la production de nouveaux nanosystemes |
KR20180066239A (ko) | 2015-10-20 | 2018-06-18 | 베. 브라운 멜중엔 악티엔게젤샤프트 | 단트롤렌을 포함하는 수성 조성물 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU201783B (en) * | 1987-10-13 | 1990-12-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing partially methylized carboxy-acyl-beta-cyclodextrines and salts |
DE3810737A1 (de) * | 1988-03-30 | 1989-10-12 | Macherey Nagel Gmbh & Co Kg | Substituierte cyclodextrine |
-
1999
- 1999-05-27 WO PCT/JP1999/002806 patent/WO1999062958A1/fr not_active Application Discontinuation
- 1999-05-27 AU AU39547/99A patent/AU3954799A/en not_active Abandoned
- 1999-05-27 JP JP2000552168A patent/JP2002517521A/ja not_active Withdrawn
- 1999-05-27 EP EP99922527A patent/EP1084149A1/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JP2002517521A (ja) | 2002-06-18 |
WO1999062958A1 (fr) | 1999-12-09 |
EP1084149A1 (fr) | 2001-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2480499A (en) | Calcification-resistant medical articles | |
AU7995300A (en) | Dithiolane derivatives | |
AU6314900A (en) | Biarylurea derivatives | |
AU6714700A (en) | Cyclopropylindole derivatives | |
AU7714300A (en) | Extended wrap label | |
AU1804101A (en) | Cooling article | |
AU1447601A (en) | Product packaging arrangement having retainer | |
AU1489001A (en) | Pocket design for absorbent article | |
AU5161399A (en) | N-benzocycloalkyl-amide derivatives and their use as medicaments | |
AU6014900A (en) | Staurosporin derivatives | |
AU7581300A (en) | Highly stable packaging substrates and brominated indane derivatives | |
AU6461599A (en) | Packaging for medicaments | |
AU1698601A (en) | Packaged skin product | |
AU7662600A (en) | 13-alkyl epothilone derivatives | |
AU7952800A (en) | 2-alkoxybenzene derivatives | |
AU2291901A (en) | Pocket design for absorbent article | |
AU6263400A (en) | Polyisocyanate-polyaddition products | |
AU1068199A (en) | Individually packaged absorbent article | |
AU1548101A (en) | Sphingosine derivatives | |
AU3198299A (en) | Multi-carotenoid product | |
AU3954799A (en) | Acylated alkylated cyclodextrin derivatives and their use as carriers for medicaments | |
AU7705100A (en) | Conveyor carrier | |
AU2001274535A1 (en) | Hydroxyformamidine derivatives and medicines containing the same | |
AU1186199A (en) | Individually packaged absorbent article | |
AU1887301A (en) | Heterocycle derivatives and drugs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |